Hematology Archives - Xtalks

Wednesday, August 12, 2026 | 11am EDT: Accelerate Cell Culture Media Development with Automated Cell Analysis

FDA Approves Tregzi: A New Way to Reduce Complications After Blood Cancer Transplants

Hemab Therapeutics IPO Raises $346.7M for Bleeding Disorder Pipeline

FDA Clears AbbVie’s Decnupaz for Ultra-Rare Blood Cancer BPDCN

World Blood Cancer Day 2026: New FDA Approvals and Phase III Readouts

World Hemophilia Day 2026: New Treatment Era and Improving Diagnosis

Redefining Hematologic Malignancy Drug Development: How Molecular Reclassification, MRD, & AI is Reshaping Precision Hematology

Accrufer Becomes First FDA-Approved Prescription Iron Therapy for Children 10+

Omisirge Wins FDA Approval as First Cell Therapy for Severe Aplastic Anemia

December 9, 2025

Sanofi’s Wayrilz (Rilzabrutinib) Wins FDA Approval as First BTK Inhibitor for ITP

September 12, 2025

Top 10 Best-Selling Hematology Drugs to Look Out For in 2025

August 25, 2025

World Blood Donor Day 2025: Honoring Lifesavers to Exploring the Future of Universal Artificial Blood

World Blood Cancer Day 2025: New Strides in Treating Leukemia, Lymphoma and Rare Blood Malignancies

Advancing Rare Disease Trials: Innovation, Partnerships and a Patient Focus

World Hemophilia Day 2025: Women and Girls Deserve Recognition Too

Rusfertide Cuts Phlebotomy Frequency and Boosts Hematocrit Control in Polycythemia Vera Trial

Roche’s VENTANA Assay for B-Cell Lymphoma Gets FDA Clearance

January 13, 2025

Next Page »